Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > New company post on LinkedIn and twitter
View:
Post by LithLover on Apr 22, 2021 7:17pm

New company post on LinkedIn and twitter

Stage posted a link to the article below on their social media with this intro comment:

"Studies have shown an alarming drop in cancer screenings and more advanced cancer during the COVID-19 pandemic. Oncologists are urging Americans to get tested, read more on the national public awareness campaign from Cancer Health "


https://www.cancerhealth.com/article/oncologists-urge-americans-get-cancer-screenings-back-track
Comment by Nailbiter1 on Apr 22, 2021 7:45pm
This post has been removed in accordance with Community Policy
Comment by gojotv! on Apr 22, 2021 10:01pm
StageZero has had a stroke of luck with Covid testing this year, and is due for another when doctors see the importance of kick-starting wide-ranging cancer screening to make up for the Covid shortfall. Aristotle has been launched right on time and in the right places to get a world of disrupted oncology back on track! As for Covid testing, it is sure to go on for at least a year, as travellers re ...more  
Comment by ompong12 on Apr 22, 2021 10:16pm
I've been waiting for a video demo of Aristotle in 2 years now......i hsven't seen one!!!!....are we really taliing of real medical technology here? Or is just pure concept and base idea patterned to sentinel principle. Why tripp can't make a video demo of aristotle? Hopefully sz cone out with one
Comment by gojotv! on Apr 22, 2021 10:27pm
I'm so glad Tripp isn't wasting money making "video demos" for stupid people. There's no need, and the return on such a frivolous expenditure isn't worth it.
Comment by ompong12 on Apr 22, 2021 10:36pm
To see is to believe now after all those years of proven lies and lip service abd pure false promises....gojotv!]I'm so glad Tripp isn't wasting money making "video demos" for stupid people. There's no need, and the return on such a frivolous expenditure isn't worth it. [/quote]
Comment by NewToInvesting7 on Apr 23, 2021 7:49am
I actually wish he would release two pre-recorded video - (i) a Q&A type video, addressing some hard questions about Aristotle, HC, marketing, etc., and (ii) an introductory video introducing the HC team to the market, with each member of the HC team giving a small overview of their role and accomplishments.  Would really bring back some positive sentiment market sentiment to the company ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities